Tourmaline Bio
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
About Tourmaline Bio
Tourmaline Bio develops medicines for inflammatory and immune diseases. The company focuses on creating a pipeline of drug candidates for patients with life-altering conditions. It aims to develop new treatments for areas with high unmet medical needs.
Company Facts
- Headquarters
- New York
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00051_00100
- Funding Stage
- m_and_a
- Total Funding
- $359,500,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2024-01-25
- Website
- tourmalinebio.com
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Links
Canonical: https://fsome.com/organization/tourmaline-bio-83869 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.